Task: Answer the multiple-choice question.
Question: Which drug exhibits a -0.111% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCOc1ccc(NC2OCC(O)C(O)C2O)c([N+](=O)[O-])c1
b.) Cn1c(=O)c(C(=O)CN2CC(=O)Nc3ccccc32)c(N)n(Cc2ccccc2)c1=O
c.) COc1ccc(C(=O)NCCSc2ccccc2)cc1OC
d.) CCOC(=O)Cc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1
e.) Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(C)cc2)cc1
Answer: e. Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(C)cc2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(C)cc2)cc1
Cc1ccc(CNC(=O)CCNS(=O)(=O)c2ccc(C)cc2)cc1
N-[(4-methylphenyl)methyl]-3-[(4-methylphenyl)sulfonylamino]propanamide